News & Blog

1 minute reading time (153 words)

Long-Acting and Daily Medications to Treat Opioid Addiction Found Equally Effective

Long-Acting and Daily Medications to Treat Opioid Addiction Found Equally Effective

A new study finds a long-acting medication and a short-term drug that must be taken daily are equally effective in treating opioid addiction.

Researchers at NYU Langone Health found extended-release naltrexone (Vivitrol) was as safe and effective as more commonly prescribed buprenorphine-naloxone (Suboxone) in curtailing opioid use, relapse, treatment drop-out, and overdose.

The study, which was sponsored by the National Institute on Drug Abuse, was published in The Lancet.

The study is the first major head-to-head comparison of the treatments, according to The Washington Post. Researchers found each treatment had disadvantages. Short-acting medicines must be taken daily for years or even a lifetime. Naltrexone, which is given as a monthly injection, cannot be started until a person is fully detoxified from opioids—which more than 25 percent of the study subjects failed to do.

More than half of the study subjects relapsed at least once, regardless of which treatment they received.

Original author: Ezra
FDA Issues Advisory About Deadly Risks Associated ...
DEA Rule Allows Criminal Prosecution for Fentanyl ...

By accepting you will be accessing a service provided by a third-party external to https://alaskacicada.org/

CICADA LOGO

NCADD Affiliate of logo w

Kenai Office

10200 Kenai Spur Highway
PO Box 882
Kenai, Alaska 99611

Office Hours: 8:45am – 5:45pm

 

Homer Office

1230 Ocean Drive Unit 1
Homer,
Alaska 99603

Office Hours:  8am – 5pm,
Mon, Tues and Thurs

CALL US:     (907)283-3658

Copyright © Cook Inlet CADA 2021. All Rights Reserved.

mhpmm.com created and supported website

Search